CBAK Energy Technology is a China-based manufacturer of lithium-ion and sodium-ion rechargeable batteries, serving electric vehicles, light electric vehicles, energy storage, and power tools through its CBAK and Hitrans segments. The third-quarter report carries added weight because the company has delivered dramatic revenue growth while struggling to convert that top-line momentum into profit. In Q3 2025, revenue surged to $60.9 million and EPS came in at $0.03, a significant upside surprise. Since then, however, results have weakened: Q4 2025 posted a net loss, and Q1 2026 reported an EPS loss of $0.10. This report will show whether the company can sustain growth without sacrificing margins. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Analysts expect CBAK Energy Technology to report revenue of approximately $94.5 million for the third quarter of 2026, a notable increase from the $60.9 million recorded in the same period last year. Earnings per share consensus is less certain, with estimates ranging from roughly breakeven to about $0.03. That dispersion reflects genuine uncertainty about cost trends and product mix, particularly given the company's aggressive capacity expansion and rising raw material expenses.
The company has a mixed recent track record against estimates. It beat EPS expectations in Q3 2025 by a wide margin, then missed in Q4 2025 and again in Q1 2026, when it reported a $0.10 per-share loss against a roughly $0.05 loss estimate. Revenue, meanwhile, has been strong but volatile, driven heavily by LEV demand and the raw materials business. Key metrics to watch include gross margin, which has been under pressure, along with research and development and sales and marketing spending, both of which have risen sharply to support new products and overseas expansion.
Sentiment heading into the Q3 2026 report appears cautious. The stock has traded well below its 52-week high, and the company's repeated earnings misses have weighed on investor confidence even as revenue has climbed. The central tension is straightforward: CBAK Energy Technology is growing quickly, but rising raw material costs, heavy investment in new capacity, and the phase-out of China's export tax rebate have squeezed profitability. Investors will be looking for signs that gross margin is stabilizing and that the new 40135 and 32140 battery cell lines are scaling efficiently. A revenue beat alone may not move the stock if losses widen, while any evidence of margin recovery could shift sentiment notably.
Following the Q3 2026 release, the most important factor to monitor is gross margin. The company has reported strong revenue growth, but costs tied to raw materials and capacity expansion have repeatedly compressed profitability. If management signals that pricing or product mix is improving, it could mark a turning point.
Investors should also track the ramp of the 40135 and 32140 battery cell lines at the Dalian and Nanjing facilities. These newer, larger-format cells are central to the company's growth strategy, and management has previously pointed to strong demand. The speed at which these lines reach normal utilization will heavily influence both revenue and margins.
Demand signals from the light electric vehicle segment and the Hitrans raw materials business remain key swing factors. LEV sales have been a major growth driver, while raw materials revenue has been volatile and lower-margin. Watch for commentary on export tax rebate changes in China, which could pressure margins further, as well as any updates to full-year guidance and operating expense trends as the company balances growth investment against the push toward profitability.
When analyzing names like CBAT, I often turn to Tickeron’s AI-powered tools to cross-check patterns and comparable opportunities across the sector. The AI Screener helps filter for technical signals and fundamentals that might otherwise take hours to review manually. In this case, it highlighted how battery stocks have responded to similar capacity ramps in recent quarters, giving me additional context for what to expect around margin trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CBAT moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 39 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for CBAT crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for CBAT entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CBAT's RSI Oscillator exited the oversold zone, 27 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on CBAT as a result. In 68 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for CBAT just turned positive on October 30, 2026. Looking at past instances where CBAT's MACD turned positive, the stock continued to rise in 32 of 43 cases over the following month. The odds of a continued upward trend are 74%.
Following a +6.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBAT advanced for three days, in 180 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.881) is normal, around the industry mean (2.765). P/E Ratio (-5.806) is within average values for comparable stocks, (13.467). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (2.910). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (0.395) is also within normal values, averaging (9.055).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CBAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of lithium batteries and related renewable energy products
Industry ElectricalProducts